World Molecular Imaging Congress focuses on HuMab 5B1 antibody

MabVax Therapeutics Holdings Inc., a clinical stage oncology drug development company, recently announced that its top antibody, HuMab 5B1, will be the main focus at the World Molecular Imaging Congress (WMIC). Read More »

Scripps study may help advance drug-design biotechnology

Scientists from the Scripps Research Institute (TSRI), based in Jupiter, Florida, recently discovered structural details in proteins that could advance drug-design biotechnology. The structural details demonstrate how certain proteins can interact with two separate signals to create a single integrated output. Read More »

Study shows advances for effective, long-lasting flu vaccine

A study recently conducted by scientists from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) as well as The Scripps Research Institute (TSRI) shows a new way to produce antibodies to battle against a variety of influenza subtypes. Read More »

Clinical trials for H1N1 influenza vaccine show promise

Vaxart Inc., a clinical-stage, privately held company that creates vaccines that are given to patients in the form of tablets instead of injections, recently announced that it has received positive results from its Phase 1 clinical trial of its oral H1N1 influenza vaccine. Read More »

Google Flu Trends enters next phase

Google Flu Trends recently announced that it is moving on to a new chapter. Read More »

Researchers find certain genes key to antibiotic-resistance bacteria

Scientist at The Scripps Research Institute uncover specific set of genes that trigger antibiotic resistance. Read More »

T cells paralyzed with early inflammatory response

Researchers from UC Davis recently discovered that when CD4 T cells, which are immune cells that help to strategize the immune system’s response to invaders, have early exposure to inflammatory cytokines, the cells are paralyzed. Read More »

Alterra raises funds to fight Malaria

Alterra has joined the United Nations Foundation "Nothing But Nets" to fight against malaria by raising $105,359 in donations over the course of approximately one year. Read More »

Vaxart to present at Euro Global Summit on Vaccines

Vaxart Inc., a clinical-stage, privately held company that creates vaccines for delivery to patients through tablets instead of injections, recently announced that it will give a presentation at the sixth Euro Global Summit and Expo on Vaccines and Vaccination. Read More »

Improved methods for engineering therapeutic proteins into antibodies

A team of researchers from The Scripps Research Institute (TSRI) recently created a better way to engineer therapeutic proteins in antibodies, which would allow antibodies to persist against invading bacteria and viruses for longer periods of time. Read More »

Cellular Biomedicine Group names chief scientific officer

Yihong Yao joins biomedicine firm from MedImmune/AstraZeneca Read More »

California health officer warns public about Valley Fever

California Department of Public Health (CDPH) Director and State Health Officer Dr. Karen Smith recently warned residents of California to be cautious of Valley Fever, which is a potentially fatal infectious disease. Read More »

Arrowhead to present at Jefferies 2015 Hepatitis B Summit

Arrowhead Research Corporation recently announced that Bruce Given, the company’s chief operating officer and the head of its research and development department, will represent the company in a presentation at the Jefferies 2015 Hepatitis B Summit. Read More »

UC Davis scientists make headway in HIV fight

A team of scientists at UC Davis recently identified a specific compound that wakes up latent human immunodeficiency virus (HIV) in order to tease the virus out of hiding and then destroy it. Read More »

New Ebola vaccine trial 100 percent effective

According to a recent report from The Guardian, an Ebola vaccine trial that took place in Guinea and involved 4,000 people is considered 100 percent effective in protecting people against Ebola. Read More »

Study on the development of T follicular helper cells

A team of scientists from the La Jolla Institute for Allergy and Immunology recently identified a set of master regulators that control the development of T follicular helper cells, also called T cells or TFH cells. Read More »

New drug combination treats HIV and hepatitis C patients

Daclatasvir and sofosbuvir offer possible solution to treating co-infected patients. Read More »

AIDS funding increases in 2014

The Kaiser Family Foundation and the Joint United Nations Programme on HIV/AIDS (UNAIDS) said Tuesday that funding to fight AIDS has increased. Read More »

West Nile virus activity spreads across California

No human cases reported so far, according to state's department of public health. Read More »

Marken provides direct shipments for MERS outbreak patients

Marken, a leading clinical trial logistics organization that offers services and solutions to the life sciences industry, recently gained government approval to provide the first direct-to-patient shipment of treatments to South Korea for the Middle East Respiratory System (MERS) outbreak. Read More »